Search
- Jun 27
Brian Skorney joins BiotechTV for Analyst Thursdays and breaks down the Sarepta approval and more
Brian Skorney gives his take on biotech and discusses Sarepta, Lexeo, Gilead, Mirum, Amgen, Vertex, Neurocrine, and Applied Therapeutics.
- Jan 8
SF Healthcare Week: Baird's Brian Skorney gives his take on Monday morning's conference news
Brian Skorney comments on the Ambrx and Harpoon acquisitions, the year ahead in biotech, and his top picks Biogen, Neurocrine, and Biohaven.
- Sep 14, 2023
Baird’s Brian Skorney joins BiotechTV in New York for Analyst Thursdays
Brian Skorney discusses this week’s data from Neurocrine Biosciences and Crinetics, and comments on Amgen, Regeneron, and Arbutus.
- Jul 6, 2023
Baird's Brian Skorney joins BiotechTV for the inaugural episode of Analyst Thursdays
Brian Skorney discusses biotech's first half of 2023 and recent news from Sarepta, Regeneron, AstraZeneca, Vertex, and Biogen.
- Jan 9, 2023
Kicking off #JPM23 with Brian Skorney
R.W. Baird Senior Research Analyst Brian Skorney speaks first with BiotechTV on the Monday morning JPM23.
.png){kind=logo}
.png){kind=logo}